Literature DB >> 25317672

ACR Appropriateness Criteria(®) non-spine bone metastases.

Edward Y Kim1, Tobias R Chapman, Samuel Ryu, Eric L Chang, Nicholas Galanopoulos, Joshua Jones, Charlotte D Kubicky, Charles P Lee, Bin S Teh, Bryan J Traughber, Catherine Van Poznak, Andrew D Vassil, Kristy Weber, Simon Shek-Man Lo.   

Abstract

Bone metastases are a common clinical problem, affecting many types of cancer patients. The presence of tumor in bone can cause significant morbidity including pain, neurological dysfunction, hypercalcemia, and pathological fracture leading to functional loss. The optimal treatment of a patient with bone metastases depends on many factors, including evaluation of the patient's goals of care, performance status, mechanical stability of the affected bone, life expectancy, and overall extent of disease. Treatment options may include radiotherapy, systemic therapies, surgical stabilization, medical pain management, and radiopharmaceuticals. Ideal management of bone metastases requires a coordinated multidisciplinary approach among diagnostic radiologists, radiation oncologists, medical oncologists, orthopedic surgeons, pain specialists, physiatrists, and palliative care specialists. The American College of Radiology Appropriateness Criteria(®) are evidence-based guidelines for specific clinical conditions that are reviewed every 3 years by a multidisciplinary expert panel. The guidelines development and review include an extensive analysis of current medical literature from peer-reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.

Entities:  

Mesh:

Year:  2015        PMID: 25317672     DOI: 10.1089/jpm.2014.9395

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  5 in total

1.  Frequency of Complicated Symptomatic Bone Metastasis Over a Breadth of Operational Definitions.

Authors:  Sara R Alcorn; Christen R Elledge; Jean L Wright; Thomas J Smith; Todd R McNutt; Jacob Fiksel; Scott L Zeger; Theodore L DeWeese
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-12-02       Impact factor: 7.038

2.  PSMA PET/CT to evaluate response to SBRT for prostate cancer bone metastases.

Authors:  Igor Sadetski; Yael Eshet; Orit Kaidar-Person; Uri Amit; Liran Domachevsky; Tima Davidson; Ilana Weiss; Maoz Ben Ayun; Zvi Symon
Journal:  Rep Pract Oncol Radiother       Date:  2021-08-12

Review 3.  Translational Strategies to Target Metastatic Bone Disease.

Authors:  Gabriel M Pagnotti; Trupti Trivedi; Khalid S Mohammad
Journal:  Cells       Date:  2022-04-12       Impact factor: 7.666

4.  Considerations for Quality Improvement in Radiation Oncology Therapy for Patients with Uncomplicated Painful Bone Metastases.

Authors:  Anne M Walling; Phillip J Beron; Tania Kaprealian; Patrick A Kupelian; Neil S Wenger; Susan A McCloskey; Christopher R King; Michael Steinberg
Journal:  J Palliat Med       Date:  2017-02-23       Impact factor: 2.947

5.  The role of postoperative radiation and coordination of care in patients with metastatic bone disease of the appendicular skeleton.

Authors:  Andrew R Summers; Travis Philipp; Jacob D Mikula; Kenneth R Gundle
Journal:  Orthop Rev (Pavia)       Date:  2018-02-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.